Human Vaccines & Immunotherapeutics
Volume 18, 2022 - Issue 1
Coronavirus – Letters
Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy
Gaurav Joshia School of Pharmacy, Graphic Era Hill University, Dehradun, IndiaCorrespondence[email protected]
https://orcid.org/0000-0002-7812-2871View further author information
https://orcid.org/0000-0002-7812-2871View further author information & Ramarao Podurib GITAM Institute of Pharmacy, GITAM University, Visakhapatnam, IndiaCorrespondence[email protected]
https://orcid.org/0000-0002-8144-349XView further author information
https://orcid.org/0000-0002-8144-349XView further author information